Alcohol can impair hepatic gluconeogenesis and may mask the symptoms of hypoglycemia, making detection and treatment more challenging
The FDA and medical community emphasize caution with compounded GLP-1s Healthline+2Houston Chronicle+2 Notably, the FDA has ended certain emergency provisions allowing compounded semaglutide production, signaling that compounding may be restricted unless specific clinical justification is documented Empower Pharmacy+2Houston Chronicle+2 Pros, Risks & Monitoring At Cleveland Care Clinic, we would approach this option only under strict oversight: starting with lower doses, frequent follow-ups, lab monitoring (e.g
The 0.25mg starting dose requires 12.5 units, typically rounded to 12 or 13
However, research has not confirmed they are safe or effective for this purpose
Wilsons Disease or other copper metabolism disorders are absolute contraindications because the additional copper delivery could cause dangerous accumulation
NO REAL SUBSTANTIVE TRIALS
